When was Inner Cosmos founded?

Inner Cosmos was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is Inner Cosmos located?

Inner Cosmos is headquartered in Portola Valley, United States.

How many employees does Inner Cosmos have?

As of May 31, 2026, the latest employee count at Inner Cosmos is 15.

Is Inner Cosmos a funded company?

Inner Cosmos is a funded company, having raised a total of $11.9M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 30, 2022.

When was the latest funding round of Inner Cosmos?

Inner Cosmos' latest funding was a $***** Seed round on Nov 01, 2024, with participation from 0 investor. Its primary sector is Brain Computer Interface. In United States, the Brain Computer Interface sector has seen $576M in funding in 2026 to date.

Where does Inner Cosmos rank among its competitors?

Inner Cosmos ranks 14th amongst 42 active competitors, of which 16 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Neuralink, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Inner Cosmos?

Inner Cosmos' top competitors include Neuralink, Synchron and Freespira. Among them, Neuralink secured the most recent funding round in May, 2026.

Inner Cosmos - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of AI-based device for treating mood and addiction disorders. The company offers Digital Pill is a penny-sized device slipped under the skin to rebalance brain networks using imperceptible micro-stimulations.

Key Metrics

Founded Year

2017

Location

Portola Valley, United States

Stage

Seed

Total Funding

$11.9M in 2 rounds

Latest Funding Round

Seed, Nov 01, 2024, $*****

Investors

Lool Ventures & 6 more

Ranked

14^th among 42 active competitors

Employee Count

15 as on May 31, 2026

Similar Companies

Neuralink & 55 more

View Inner Cosmos' full profile

Inner Cosmos has raised a total funding of $11.9M over 2 rounds. Its first funding round was on Mar 30, 2022. Inner Cosmos has 7 institutional investors.

Here is the list of recent funding rounds of Inner Cosmos:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 01, 2024	6942225	Seed	8291322	8944484	3189539	5048435
Mar 30, 2022	8563420	Seed	2043236	6083765	Lool Ventures	KittyHawk Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Inner Cosmos's funding rounds and investors

The founders of Inner Cosmos are Meron Gribetz and Dan Moran.

Here are the details of Inner Cosmos' key team members:

Meron Gribetz: Co-Founder & CEO of Inner Cosmos and founder of 1 other company.
Contact Info: 1 email address
Dan Moran: Co-Founder & VP of Inner Cosmos.
Contact Info: 1 email address

View details of Inner Cosmos's Founder profiles and Board Members

Inner Cosmos' employee count trend

Inner Cosmos has 15 employees as of May 26. Here is Inner Cosmos's employee count trend over the years:

Uncover Inner Cosmos' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Inner Cosmos include Neuralink, Synchron and Freespira. Here is the list of Top 10 competitors of Inner Cosmos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralink 2016, Fremont (United States), Series E	Provider of implantable brain-computer interfaces	$1.29B	Founders Fund, Vy Capital & 37 others	66/100
2nd	Synchron 2016, Brooklyn (United States), Series D	Developer of implantable bioelectronics for the treatment of neurological conditions	$345M	Arch Venture Partners, Double Point Ventures ... & 33 others	62/100
3rd	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Lightspeed Venture Partners, Aphelion Capital ... & 4 others	60/100
4th	Motif neurotech 2022, Houston (United States), Series A	Developer of minimally invasive bioelectronics for mental health disorders	$18.8M	Arboretum Ventures, re.Mind Capital & 9 others	60/100
5th	NeuroSigma 2008, Los Angeles (United States), Seed	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	59/100
6th	Paradromics 2015, Austin (United States), Series A	Provider of data streaming brain-computer interfaces	$88.7M	Prime Movers Lab, Synergy Ventures & 29 others	58/100
7th	CorTec 2010, Freiburg im Breisgau (Germany), Series C	Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies	$21.6M	Santo Venture Capital, K & SW Consult & 7 others	57/100
8th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
9th	Cervel 2008, Redwood City (United States), Acquired	Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression	$23.6M	Aberdare Ventures, The D. E. Shaw Group & 1 others	49/100
10th	Nexalin 2010, Tustin (United States), Public	A non-invasive and drug free treatment for the treatment of anxiety, depression and insomnia	$502K	-	47/100
14th	Inner Cosmos 2017, Portola Valley (United States), Seed	Provider of AI-based device for treating mood and addiction disorders	$11.9M	Starlight Ventures, Lool Ventures & 5 others	39/100